Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The O-specific polysaccharide (OSP) antigen of *Salmonella enterica* serovar Paratyphi A is a key component of the bacterium’s lipopolysaccharide (LPS), which is a major constituent of the outer membrane in Gram-negative bacteria. The OSP forms the outermost part of LPS and plays a critical role in immune recognition, virulence, and as a target for vaccine development. The OSP consists of repeating oligosaccharide units that extend from the conserved core region of LPS. It is composed primarily of a trisaccharide backbone (rhamnose, mannose, and galactose) with branches of d-paratose and glucose. Partial O-acetylation at the C-3 position on rhamnose is also present. Antibodies against the OSP can mediate bactericidal activity and are considered protective. Conjugate vaccines using detoxified or isolated S. Paratyphi A OSP linked to carrier proteins have shown promising results. It defines serogroup A within Salmonella species.
Antibodies targeting the OSP mediate bactericidal activity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Salmonella Paratyphi A O-specific Polysaccharide Antigen (Paratyphi A OSP).